Illuminating the Brain: Advances in Neurobiology
Watch leading experts in neurobiology imaging in a virtual symposium exploring cutting-edge multi-modal approaches using ultra-high frequency ultrasound and photoacoustics.
Scaling AAV9 Manufacturing: A Blueprint for Clinical-Grade Gene Therapy Production
Learn how to overcome AAV9 bottlenecks with an open-source, high-yield manufacturing blueprint designed to accelerate clinical-grade gene therapy production.
Pathophysiology of Endometriosis: Current Concepts and Clinical Translations
Join Dr. Rick Burney to explore the pathogenesis, advances, and ongoing clinical challenges in endometriosis research.
Supporting the Development of Biologics Through the IND‑Enabling Studies and Clinical Phases
In this webinar, Dr. Linda Randall shares how Pharmaron’s global teams are supporting the development of biological drugs from discovery to commercial supply.
From Bench to Clinic: Decoding the IND Roadmap for Innovative Cell and Gene Therapies
Join Dr. Grace Lee and Dr. Frederik Deroose as they discuss important considerations and challenges during the Investigational New Drug (IND) application process, with a focus on cell and gene therapy.
#ExpertAnswers: Christopher Perry and Homira Osman on Integrating Patients, Clinical, and Advocacy Partners with Preclinical Research Labs
Dr. Christopher Perry, York University and Dr. Homira Osman, Muscular Dystrophy Canada answer questions from a recent webinar on how the integration of clinical, industrial, and not-for-profit advocacy partners with preclinical research labs offers great potential to improve our research impact.
Integrating Patient Engagement and Trainee Development in Pre-Clinical Research
Christopher Perry, PhD discusses how his laboratory aims to discover mechanisms by which metabolic dysfunction causes muscle weakness and apply these findings to develop new therapies for muscle disorders. Homira Osman, PhD provides a particular focus on leveraging scientific findings for practice and policy and linking trainees with patient communities.
Partnering with Disease Registries: The Value and Impact for Real-World Evidence Generation
In this webinar, Evidera experts present guidance on why strong connections with registry groups and stakeholder populations are important for generating relevant real-world evidence to advance treatments.
Minimizing the Impact of Cross-Cultural Differences in COA Translations
ICON's COA Linguistic Validation Leaders highlight the importance of Linguistic Validation and how equivalence should be a key focus during the development of Clinical Outcome Assessment translations.
Bruker Virtual NMR Users Meeting
The Bruker Users Meeting is an annual gathering of our NMR community and a chance to listen, learn, and share knowledge and ideas.
